| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2002;33:2877.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology and Neurological Surgery (Neurological Surgery)(D.J.F., R.L.G., K.M.R., M.R.C., R.G.D.), Interventional Neuroradiology Service (C.J.M., D.T.C., C.P.D.), and Mallinckrodt Institute of Radiology (C.J.M., D.T.C., R.L.G., K.M.R., R.G.D., C.P.D.), Washington University School of Medicine, St. Louis, Mo.
Correspondence to Dr Colin Derdeyn, 510 S Kingshighway Blvd, St Louis, MO 63110. E-mail derdeync{at}mir.wustl.edu
Background and Purpose The optimal treatment of patients with symptomatic carotid stenosis who are poor surgical candidates is uncertain. The purposes of this study were to report the long-term outcome after angioplasty in a series of these patients and to compare these data with historical control data from the North American Symptomatic Carotid Endarterectomy Trial (NASCET).
Methods We identified 42 consecutive patients with >70% carotid stenosis and ipsilateral ischemic symptoms within 120 days of treatment with angioplasty. All were considered poor surgical candidates by experienced surgeons. Baseline epidemiological stroke risk factors were obtained from review of medical records. Follow-up was from clinic records and by telephone.
Results Baseline epidemiological stroke risk factors were similar to those of medically treated NASCET patients. Angioplasty patients tended to have higher degrees of stenosis (45% with >90% stenosis versus 24% in NASCET) and more frequent contralateral stenosis or occlusion (30% versus 9%) than NASCET patients. Three patients suffered procedural strokes; 2 of the 3 made nearly complete recoveries. One additional patient suffered a central retinal occlusion 48 hours after angioplasty. No ipsilateral strokes occurred during the mean follow-up period of 1.7 years. Three patients were lost to follow-up. The cumulative risk of stroke was 9.5% (4 of 42) compared with 26% at 2 years for medically treated patients in NASCET.
Conclusions These pilot data suggest a beneficial effect of angioplasty for patients with high-grade symptomatic carotid stenosis who are not good surgical candidates.
Key Words: angioplasty carotid endarterectomy carotid stenosis stents
This article has been cited by other articles:
![]() |
M. Onizuka, K. Kazekawa, S. Nagata, M. Tsutsumi, H. Aikawa, M. Tomokiyo, M. Iko, T. Kodama, K. Nii, S. Matsubara, et al. The Significance of Incomplete Stent Apposition in Patients Undergoing Stenting of Internal Carotid Artery Stenosis AJNR Am. J. Neuroradiol., August 1, 2006; 27(7): 1505 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kohyama, K. Kazekawa, M. Iko, H. Aikawa, M. Tsutsumi, Y. Go, S. Nagata, T. Kodama, K. Nii, S. Matsubara, et al. Spontaneous Improvement of Peristent Ulceration after Carotid Artery Stenting AJNR Am. J. Neuroradiol., January 1, 2006; 27(1): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Linfante, J. A. Hirsch, M. Selim, G. Schlaug, L. R. Caplan, and A. S. Reddy Safety of Latest-Generation Self-expanding Stents in Patients With NASCET-Ineligible Severe Symptomatic Extracranial Internal Carotid Artery Stenosis Arch Neurol, January 1, 2004; 61(1): 39 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lucertini, D.L. Fox, C.P. Derdeyn, C.J. Moran, D.T. Cross III, R.L. Grubb Jr, and R.G. Dacey Jr Carotid Angioplasty With Stenting and Carotid Endarterectomy for High-Risk Patients * Response Stroke, June 1, 2003; 34 (6): e42 - e43. [Full Text] [PDF] |
||||
![]() |
E. Ballotta, G. D. Giau, C. Baracchini, C. P. Derdeyn, D. Fox, C. J. Moran, D. T. Cross III, and R. G. Dacey Jr Carotid Angioplasty and Stenting in High-Risk Patients With Severe Symptomatic Carotid Stenosis Stroke, April 1, 2003; 34(4): 834 - 835. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |